BRIEF published on 11/10/2026 at 10:05, 14 hours 38 minutes ago GENFIT Discloses Total Shares and Voting Rights as of October 2026 Voting Rights Capital Disclosure AMF Regulation October 2026 GENFIT Shares
PRESS RELEASE published on 11/10/2026 at 10:00, 14 hours 43 minutes ago Disclosure of the Total Number of Voting Rights and Shares Forming the Share Capital
BRIEF published on 11/09/2026 at 07:35, 1 day 17 hours ago GENFIT continues the development of nangibotide in ACLF with promising results Phase 2 Inflammation GENFIT ACLF Nangibotide
BRIEF published on 11/09/2026 at 07:35, 1 day 17 hours ago GENFIT Unveils Clinical Insights on Nangibotide for ACLF Clinical Trials GENFIT ACLF Nangibotide TREM-1 Modulation
PRESS RELEASE published on 11/09/2026 at 07:30, 1 day 17 hours ago GENFIT Highlights Data from Clinical Studies of Nangibotide, Supporting Its Advancement into ACLF with Phase 2 Data Expected in 2027
BRIEF published on 11/02/2026 at 07:35, 8 days 17 hours ago GENFIT Highlights Advances in ACLF and MASH Diagnostics at AASLD 2026 Diagnostics GENFIT ACLF MASH Nangibotide
BRIEF published on 11/02/2026 at 07:35, 8 days 17 hours ago GENFIT highlights its innovations at the Liver Meeting 2026 GENFIT ACLF Liver Meeting 2026 MASH Diagnosis NIS™ Technologies
PRESS RELEASE published on 11/02/2026 at 07:30, 8 days 17 hours ago GENFIT to Highlight Progress in ACLF and MASH Diagnostics at AASLD The Liver Meeting® 2026
BRIEF published on 09/28/2026 at 19:56, 1 month 12 days ago GENFIT Announces H1 2026 Financial Performance and Strategic Developments R&D Pipeline GENFIT Financials Biopharmaceutical Developments MASH Diagnostics Ipsen Agreement
PRESS RELEASE published on 09/28/2026 at 19:51, 1 month 12 days ago GENFIT Reports First-Half 2026 Financial Results and Provides Corporate Update GENFIT reports first-half 2026 financial results and provides corporate update including significant revenue growth, strategic developments and future milestones Revenues Financial Results Corporate Update Milestones GENFIT
Published on 11/10/2026 at 23:30, 1 hour 14 minutes ago CCL Industries Announces 2026 Third Quarter Results
Published on 11/10/2026 at 23:00, 1 hour 44 minutes ago Vanta Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/10/2026 at 23:00, 1 hour 44 minutes ago Battery X Metals Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/10/2026 at 23:00, 1 hour 44 minutes ago Condor Agrees to Short Extension of Lucero Closing Payment with ELEMENT79 and Provides Huiñac Punta Drill Program Update
Published on 11/10/2026 at 22:30, 2 hours 14 minutes ago Amdocs Announces First Quarter Fiscal 2027 Investor Conference Schedule
Published on 11/11/2026 at 00:15, 28 minutes ago Lean Focus Launches Asia Pacific: Local Expertise. Global Impact.
Published on 11/10/2026 at 23:15, 1 hour 28 minutes ago GSMA MWC26 Doha welcomed over 10,000 attendees, as world-first ITU co-location puts MENA at the centre of global connectivity policy and innovation
Published on 11/10/2026 at 18:54, 5 hours 49 minutes ago REPLOID Group AG pursues entry in the US market and secures exclusivity to conduct due diligence for the potential acquisition of Chapul, LLC.
Published on 11/10/2026 at 17:31, 7 hours 12 minutes ago CNP Assurances SA announces the success of the issuance of a €500 million Tier 2 subordinated bond.
Published on 11/10/2026 at 14:00, 10 hours 43 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from November 2 to November 6, 2026
Published on 11/10/2026 at 11:02, 13 hours 41 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 17 hours 44 minutes ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/09/2026 at 18:30, 1 day 6 hours ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
